搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
Modern Healthcare
3 小时
GLP-1 costs drive employers to specialty benefits vendors
Employers that cover GLP-1s are partnering with vendors to design benefits and manage lifestyle programs, but the "jury is ...
FierceBiotech
1 天
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
Recently debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, revealing a 7.5% reduction in body ...
The Harvard Crimson
8 小时
HMS Professor Wins Prestigious Lasker-DeBakey Award for Work on GLP-1
Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...
4 天
Do GLP-1 supplements work? What to know about ‘nature's Ozempic'
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...
6 天
on MSN
Do ‘Natural GLP-1 Supplements’ Actually Work As Well As Ozempic?
Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...
4 天
Ozempic: GLP-1 Drugs May Help Prevent 34,000 Heart Attacks and Strokes Per Year
GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
3 天
Does ‘nature’s Ozempic’ really work? Trendy GLP-1 supplements are designed to ...
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
13 小时
on MSN
Mizuho's Jared Holz talks what senate hearings mean for GLP-1 makers
Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk CEO defending GLP-1 pricing and the push to lower prices.
15 小时
on MSN
GLP-1 demand is going to remain higher than supply for foreseeable future, says BMO's Evan ...
Evan Seigerman, BMO senior analyst, joins 'Closing Bell Overtime' to talk today's Capitol Hill hearing with Novo Nordisk's ...
STAT
23 小时
Metsera’s GLP-1 drug has potential for monthly dosing, new data show
Novo Nordisk CEO Lars Fruergaard Jørgensen will testify at a Senate hearing today about the prices of Ozempic and Wegovy.
4 天
What Experts Think About Lemme's New GLP-1 Supplement
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈